South Korea
· Delayed Price · Currency is KRW Daelim Bath Statistics
Total Valuation
Daelim Bath has a market cap or net worth of KRW 70.61 billion. The enterprise value is 129.34 billion.
| Market Cap | 70.61B |
| Enterprise Value | 129.34B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Daelim Bath has 16.42 million shares outstanding.
| Current Share Class | 16.42M |
| Shares Outstanding | 16.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 57.28% |
| Owned by Institutions (%) | 0.03% |
| Float | 5.35M |
Valuation Ratios
The trailing PE ratio is 11.19.
| PE Ratio | 11.19 |
| Forward PE | n/a |
| PS Ratio | 0.24 |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | 4.32 |
| P/OCF Ratio | 3.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.90, with an EV/FCF ratio of 7.92.
| EV / Earnings | 20.18 |
| EV / Sales | 0.44 |
| EV / EBITDA | 5.90 |
| EV / EBIT | 10.74 |
| EV / FCF | 7.92 |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.10 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 3.73 |
| Debt / FCF | 5.01 |
| Interest Coverage | 2.74 |
Financial Efficiency
Return on equity (ROE) is 4.65% and return on invested capital (ROIC) is 2.99%.
| Return on Equity (ROE) | 4.65% |
| Return on Assets (ROA) | 2.18% |
| Return on Invested Capital (ROIC) | 2.99% |
| Return on Capital Employed (ROCE) | 5.48% |
| Revenue Per Employee | 412.74M |
| Profits Per Employee | 9.05M |
| Employee Count | 708 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 4.47 |
Taxes
In the past 12 months, Daelim Bath has paid 881.79 million in taxes.
| Income Tax | 881.79M |
| Effective Tax Rate | 10.57% |
Stock Price Statistics
The stock price has increased by +2.00% in the last 52 weeks. The beta is 0.60, so Daelim Bath's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +2.00% |
| 50-Day Moving Average | 4,102.60 |
| 200-Day Moving Average | 3,818.25 |
| Relative Strength Index (RSI) | 58.50 |
| Average Volume (20 Days) | 159,091 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Daelim Bath had revenue of KRW 292.22 billion and earned 6.41 billion in profits. Earnings per share was 384.44.
| Revenue | 292.22B |
| Gross Profit | 70.30B |
| Operating Income | 12.05B |
| Pretax Income | 8.34B |
| Net Income | 6.41B |
| EBITDA | 21.92B |
| EBIT | 12.05B |
| Earnings Per Share (EPS) | 384.44 |
Balance Sheet
The company has 30.93 billion in cash and 81.76 billion in debt, giving a net cash position of -50.83 billion or -3,095.16 per share.
| Cash & Cash Equivalents | 30.93B |
| Total Debt | 81.76B |
| Net Cash | -50.83B |
| Net Cash Per Share | -3,095.16 |
| Equity (Book Value) | 160.99B |
| Book Value Per Share | 9,288.01 |
| Working Capital | 11.56B |
Cash Flow
In the last 12 months, operating cash flow was 17.89 billion and capital expenditures -1.57 billion, giving a free cash flow of 16.33 billion.
| Operating Cash Flow | 17.89B |
| Capital Expenditures | -1.57B |
| Free Cash Flow | 16.33B |
| FCF Per Share | 994.26 |
Margins
Gross margin is 24.06%, with operating and profit margins of 4.12% and 2.19%.
| Gross Margin | 24.06% |
| Operating Margin | 4.12% |
| Pretax Margin | 2.86% |
| Profit Margin | 2.19% |
| EBITDA Margin | 7.50% |
| EBIT Margin | 4.12% |
| FCF Margin | 5.59% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 3.49%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 3.49% |
| Dividend Growth (YoY) | 36.36% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.59% |
| Earnings Yield | 9.08% |
| FCF Yield | 23.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Daelim Bath has an Altman Z-Score of 1.75 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.75 |
| Piotroski F-Score | 7 |